Table 1.
Resistance Profiles | No of Isolates | MAR Index |
---|---|---|
Fully susceptible | ||
Total | 47 | ≤0.2 |
Percentage | 47/78 (60.2%) | |
Single resistance | ||
AZM | 1 | ≤0.2 |
AMP | 5 | ≤0.2 |
CTX | 3 | ≤0.2 |
TE | 2 | ≤0.2 |
SXT | 2 | ≤0.2 |
CN | 1 | ≤0.2 |
Total | 14 | |
Percentage | 14/78 (17.9%) | |
Double resistance | ||
AMP, TE | 1 | ≤0.2 |
AZM, AMP | 2 | ≤0.2 |
C, TE | 1 | ≤0.2 |
AMP, CAZ | 1 | ≤0.2 |
AMP, LEV | 1 | |
Total | 6 | |
Percentage | 6/78 (7.7%) | |
MDR | ||
C, SXT, TE | 3 | ≥0.2 |
CN, AMP, TE | 1 | ≥0.2 |
SXT, AMP, TE | 1 | ≥0.2 |
SXT, TE, CAZ | 1 | ≥0.2 |
F, AZM, TE | 1 | ≥0.2 |
C, SXT, AMP | 1 | ≥0.2 |
CN, C, AMP, LEV | 1 | ≥0.2 |
F, AZM, AMP, TE | 1 | ≥0.2 |
CN, LEV, AZM, SXT, AMP, TE | 1 | ≥0.2 |
Total | 11 | |
Percentage | 11/78 (14.1%) |
Legend: AMP: Ampicillin, AZM: Azithromycin, CTX: Cefotaxime, TE: Tetracycline, CN: Gentamicin SXT: Sulphamethoxazole-Trimethoprim, C: Chloramphenicol, CAZ: Ceftazidime, LEV: Levofloxacin, F: Nitrofurantoin.